Biochemistry
-
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite
This article has 23 authors:Reviewed by ScreenIT
-
Development of a simple in vitro assay to identify and evaluate nucleotide analogs against SARS-CoV-2 RNA-dependent RNA polymerase
This article has 9 authors:Reviewed by ScreenIT
-
Ebselen derivatives are very potent dual inhibitors of SARS-CoV-2 proteases - PL pro and M pro in in vitro studies
This article has 14 authors:Reviewed by ScreenIT
-
Identification of low micromolar SARS-CoV-2 M pro inhibitors from hits identified by in silico screens
This article has 10 authors:Reviewed by ScreenIT
-
A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells
This article has 29 authors:Reviewed by ScreenIT
-
Cold sensitivity of the SARS-CoV-2 spike ectodomain
This article has 23 authors:Reviewed by ScreenIT
-
Cytoplasmic short linear motifs in ACE2 and integrin β3 link SARS-CoV-2 host cell receptors to endocytosis and autophagy
This article has 3 authors:Reviewed by ScreenIT
-
A SARS-CoV-2 spike binding DNA aptamer that inhibits pseudovirus infection in vitro by an RBD independent mechanism
This article has 7 authors:Reviewed by ScreenIT
-
Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
This article has 10 authors:Reviewed by ScreenIT
-
A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2
This article has 7 authors:Reviewed by ScreenIT